2022 - Research.com Best Female Scientist Award
The scientist’s investigation covers issues in Internal medicine, Kidney disease, Renal function, Intensive care medicine and Surgery. Her Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and Cardiology. Her Kidney disease research is multidisciplinary, incorporating elements of Nephrology, Comorbidity, Disease, Pathology and Acute kidney injury.
Her Renal function research integrates issues from Creatinine, Kidney, Proteinuria and Cohort. Brenda R. Hemmelgarn has included themes like Albuminuria and Urology in her Creatinine study. Her Intensive care medicine research is multidisciplinary, relying on both Cancer, Epidemiology, Guideline, Emergency medicine and Meta-analysis.
Internal medicine, Kidney disease, Intensive care medicine, Renal function and Cohort are her primary areas of study. Brenda R. Hemmelgarn has researched Internal medicine in several fields, including Surgery and Cardiology. Her Kidney disease research includes elements of Diabetes mellitus, Randomized controlled trial, Disease, End stage renal disease and Hazard ratio.
Her work carried out in the field of Randomized controlled trial brings together such families of science as Meta-analysis and Physical therapy. Her study ties her expertise on Epidemiology together with the subject of Intensive care medicine. Urology is closely connected to Creatinine in her research, which is encompassed under the umbrella topic of Renal function.
Her primary areas of investigation include Kidney disease, Internal medicine, Cohort study, Renal function and Cohort. Brenda R. Hemmelgarn has researched Kidney disease in several fields, including Psychological intervention, Family medicine, Confidence interval, Intensive care medicine and Dialysis. Her work on Internal medicine deals in particular with Nephrology, Absolute risk reduction, Kidney, Disease and Hazard ratio.
Her Cohort study research incorporates elements of Odds ratio, Renal replacement therapy and Retrospective cohort study. Brenda R. Hemmelgarn is involved in the study of Renal function that focuses on Albuminuria in particular. The Cohort study combines topics in areas such as Vascular surgery and Surgery.
Brenda R. Hemmelgarn mainly focuses on Kidney disease, Internal medicine, Renal function, Albuminuria and Family medicine. Her Kidney disease research integrates issues from Renal replacement therapy, Intensive care medicine, Dialysis and Confidence interval. Brenda R. Hemmelgarn is interested in Absolute risk reduction, which is a field of Internal medicine.
The various areas that Brenda R. Hemmelgarn examines in her Renal function study include Acute kidney injury, Cohort study and Cohort. Her research in Albuminuria intersects with topics in Creatinine, Proteinuria and Urology. Her Family medicine research includes themes of Nephrology and Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward.
The Lancet (2010)
Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
A Levin;PE Stevens;RW Bilous;J Coresh.
Kidney International (2013)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
Ron T Gansevoort;Ricardo Correa-Rotter;Brenda R Hemmelgarn;Tazeen H Jafar.
The Lancet (2013)
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Brenda R. Hemmelgarn;Braden J. Manns;Anita Lloyd;Matthew T. James.
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
Kunihiro Matsushita;Bakhtawar K. Mahmoodi;Bakhtawar K. Mahmoodi;Mark Woodward;Jonathan R. Emberson.
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
Bruce F. Culleton;Michael Walsh;Scott W. Klarenbach;Garth Mortis.
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.
Marcello Tonelli;Paul Muntner;Anita Lloyd;Braden J Manns.
The Lancet (2012)
Early recognition and prevention of chronic kidney disease.
Matthew T James;Brenda R Hemmelgarn;Marcello Tonelli.
The Lancet (2010)
Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta‐analysis of randomized controlled trials
M. J. Armstrong;T. A. Mottershead;P. E. Ronksley;R. J. Sigal.
Obesity Reviews (2011)
Benzodiazepine Use and the Risk of Motor Vehicle Crash in the Elderly
B Hemmelgarn;S Suissa;A Huang;J.F Boivin.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: